Avacta Group Plc (AIM:AVCT)
London · Delayed Price · Currency is GBP · Price in GBX 73.00
-1.00 (-1.35%)
Sep 25, 2026, 1:07 PM GMT
Avacta Group Market Cap
Avacta Group has a market cap or net worth of 346.62 million as of September 24, 2026. Its market cap has increased by 60.28% in one year.
Market Cap
346.62M
Enterprise Value
347.47M
Revenue
113.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
73.00
ChartMarket Cap Chart
Since September 29, 2006, Avacta Group's market cap has increased from 37.46M to 346.62M, an increase of 825.31%. That is a compound annual growth rate of 11.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 346.62M | 37.88% |
| Dec 31, 2025 | 251.39M | 37.41% |
| Dec 31, 2024 | 182.95M | -43.88% |
| Dec 29, 2023 | 325.99M | 9.26% |
| Dec 30, 2022 | 298.35M | -5.82% |
| Dec 31, 2021 | 316.78M | 11.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.71B |
| Genus | 1.41B |
| Oxford Biomedica | 593.09M |
| PureTech Health | 284.41M |
| Scancell Holdings | 117.59M |
| 4basebio | 87.40M |
| Bioventix | 80.99M |
| Faron Pharmaceuticals Oy | 73.32M |